Elizabeth I Buchbinder (Elizabeth Buchbinder)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Topics

Basal Cell Carcinoma

Helicobacter Pylori

Top Venues

Cancer research communications

Journal for immunotherapy of cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott, F Stephen Hodi, Tamara A Sussman, Ann W Silk, Rizwan Haq, David Liu, Megan Insco, Elizabeth I Buchbinder
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Journal for immunotherapy of cancer 12 (8) (2024)
Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott, F Stephen Hodi, Tamara A Sussman, Ann W Silk, Rizwan Haq, David Liu, Megan Insco, Elizabeth I Buchbinder
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Journal for immunotherapy of cancer 12 (8) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Alexander Z Wei, Lanyi N Chen, Marlana Orloff, Charlotte E Ariyan, Maryam Asgari, Christopher A Barker, Elizabeth I Buchbinder, Sunandana Chandra, Kasey Couts, Michael M Frumovitz, Andrew Futreal, Jeffrey E Gershenwald, Ehab Y Hanna, Benjamin Izar, Amy K LeBlanc, Mario M Leitao, Evan J Lipson, David Liu, Martin McCarter, Jennifer L McQuade, Yana Najjar, Suthee Rapisuwon, Sara Selig, Alexander N Shoushtari, Iwei Yeh, Gary K Schwartz, Jun Guo, Sapna Pradyuman Patel, Richard D Carvajal
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment cell & melanoma research (2023)
Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, Lancia N F Darville, Aparna Raj Parikh, Elizabeth I Buchbinder, Justine V Cohen, Donald P Lawrence, Geoffrey I Shapiro, Harold Keer, Helen X Chen, Susan Percy Ivy, Keiran S M Smalley, John M Koomen, Ryan J Sullivan
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. Cancer (2023)
Aneesha Haryal, Matthew J Townsend, Vinitha Baskaran, Padmavathi Srivoleti, Anita Giobbie-Hurder, Jordan S Sack, Raymond A Isidro, Nicole R LeBoeuf, Elizabeth I Buchbinder, F Stephen Hodi, Shilpa Grover
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer (2022)
Elizabeth I Buchbinder, Jason L Weirather, Michael Manos, Brian J Quattrochi, Lynette M Sholl, Ryan C Brennick, Peter Bowling, Nancy Bailey, Lisa Magarace, Patrick A Ott, Rizwan Haq, Benjamin Izar, Anita Giobbie-Hurder, F Stephen Hodi
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. Cancer medicine 10 (8) (2021)
Elizabeth I Buchbinder, Janice P Dutcher, Gregory A Daniels, Brendan D Curti, Sapna P Patel, Shernan G Holtan, Gerald P Miletello, Mayer N Fishman, Rene Gonzalez, Joseph I Clark, John M Richart, Christopher D Lao, Scott S Tykodi, Ann W Silk, David F McDermott
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition. Journal for immunotherapy of cancer 7 (1) (2019)
Nageatte Ibrahim, Elizabeth I Buchbinder, Scott R Granter, Scott J Rodig, Anita Giobbie-Hurder, Carla Becerra, Argyro Tsiaras, Evisa Gjini, David E Fisher, F Stephen Hodi
A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. Cancer medicine 5 (11) (2016)